Sapporo Medical University, Fujitsu Limited, and Fujitsu Hokuriku Systems Limited today announced that this month they will begin development of an AI machine learning model to optimize prescription of oral hypoglycemic medicines in the treatment of diabetes, as part of joint research on AI use with clinical data.
To share please enter your Email address
To Add Following, please enter Email address
To Save Content please enter Email address